# Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial

> **NCT04274608** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Tan Tock Seng Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Obesity
- Weight Loss

## Interventions

- **DRUG:** Botulinum toxin type A
- **BEHAVIORAL:** Weight Management Program

## Key facts

- **NCT ID:** NCT04274608
- **Lead sponsor:** Tan Tock Seng Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2021-07
- **Final completion:** 2022-07
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2020-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04274608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04274608, "Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04274608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*